COMMUNIQUÉS West-GlobeNewswire

Novartis renouvelle son engagement afin d'éliminer le paludisme en investissant 100 millions de dollars dans la recherche et le développement d'antipaludiques de nouvelle génération

17/04/2018 - 07:16

L'entreprise s'apprête à investir plus de 100 millions de dollars afin de faire progresser la recherche et le développement de nouveaux antipaludiques au cours des cinq prochaines années L'engagement inclut également l' [...]

Basilea licenses late-stage oncology drug candidate derazantinib from ArQule

17/04/2018 - 07:16

Basel, Switzerland, April 17, 2018 - Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that it has entered into a license agreement with ArQule, Inc. (NASDAQ: ARQL) for its oncology drug candidate ARQ 087 ( [...]

Veloxis Pharmaceuticals A/S Grants Warrants Under Existing Warrant Program

17/04/2018 - 07:12

Company Release no. 10/2018 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 17 April 2018 Veloxis Pharmaceuticals A/S Grants Warrants Under Existing Warrant Program Today, the Board of Directors of Veloxis [...]

PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")

17/04/2018 - 07:01

REGULATED INFORMATION GHENT, Belgium, 17 April 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]

INNATE PHARMA : AACR 2018, New preclinical data further support ongoing programs

17/04/2018 - 07:01

new preclinical data further support ongoing programs and highlight next generation of immunotherapies Next generation of immunotherapies presented by Chief Scientific Officer Eric Vivier in a meet-the-expert session at [...]

INNATE PHARMA : AACR 2018 Nouvelles données précliniques renforçant le rationnel des programmes en cours

17/04/2018 - 07:01

NOUVELLES DONNEES PRECLINIQUES RENFORÇANT LE RATIONNEL DES PROGRAMMES EN COURS POUR UNE PROCHAINE GENERATION D'IMMUNOTHERAPIES Prochaine génération d'immunothérapies présentée par Eric Vivier, Directeur Scientifique, [...]

Novartis tender offer for AveXis commences

17/04/2018 - 07:01

Basel, April 17, 2018 - Novartis AG (NYSE: NVS) ("Novartis") today announced that its indirect wholly-owned subsidiary, Novartis AM Merger Corporation, a Delaware corporation ("Purchaser"), has commenced a cash tender [...]

REVA to Present Full Two-Year FANTOM II Data at EuroPCR

17/04/2018 - 01:34

SAN DIEGO, April 16, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular applications, announced that it will be presenting two- [...]

Apellis Pharmaceuticals Announces Proposed Offering of Common Stock

16/04/2018 - 23:12

CRESTWOOD, Ky. and WALTHAM, Mass., April 16, 2018 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS ), a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds [...]

Boston Marathon Athlete Attempting to Break the Guinness World Record for the Fastest Marathon Ever Run Backwards Finishes Race in 5 Hours, 43 Minutes, 59 Seconds

16/04/2018 - 23:04

BOSTON, April 16, 2018 (GLOBE NEWSWIRE) -- Los Angeles native and Disney movie production lawyer, Loren Zitomersky (aka “The Backwards Guy”), attempted to break the Guinness World Record for the fastest marathon ever [...]

Advanced Proteome Therapeutics Announces Appointment of New Board Members

16/04/2018 - 23:04

VANCOUVER, British Columbia, April 16, 2018 (GLOBE NEWSWIRE) -- Advanced Proteome Therapeutics Corporation (“ APC ” or the “ Company ”) (TSXV:APC) (FSE:0E8) is pleased to announce the appointments of Dr. John R. Garrett [...]

Bellicum Pharmaceuticals Announces Proposed Public Offering of Common Stock

16/04/2018 - 22:42

HOUSTON, April 16, 2018 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM ), a clinical stage biopharmaceutical company focused on discovering and developing cellular immunotherapies for cancers and [...]

Mateon Therapeutics Provides Business Update and Reports 2017 Financial Results

16/04/2018 - 22:35

SOUTH SAN FRANCISCO, Calif., April 16, 2018 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (OTCQX:MATN), a biopharmaceutical company developing investigational drugs for the treatment of orphan oncology indications, [...]

HTG Promotes John Lubniewski to President and Chief Operating Officer

16/04/2018 - 22:15

Mr. Lubniewski assumes the role after having served for seven years as Chief Business Officer TUCSON, Ariz., April 16, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM ), a provider of instruments [...]

Mateon Therapeutics Raises Net Proceeds of Approximately $2.4 Million in Financing Transaction

16/04/2018 - 22:10

SOUTH SAN FRANCISCO, Calif., April 16, 2018 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc . (OTCQX:MATN), a biopharmaceutical company developing investigational drugs for the treatment of orphan oncology indications, [...]

IRIDEX Announces Appointment of Maria Sainz and David Bruce to its Board of Directors

16/04/2018 - 22:05

MOUNTAIN VIEW, Calif., April 16, 2018 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX ) today announced the appointment of Maria Sainz and David Bruce to the Company’s Board of Directors effective as of April 13, [...]

Novavax Announces Closing of Public Offering

16/04/2018 - 22:05

GAITHERSBURG, Md., April 16, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX ), a clinical-stage biotechnology company committed to delivering novel products to prevent infectious diseases, today announced the [...]

Microbot Medical Exercises Option to Acquire Novel Technology from CardioSert Ltd.

16/04/2018 - 22:01

Expands Intellectual Property (IP) Portfolio, Addressable Markets and Barriers of Entry HINGHAM, Mass., April 16, 2018 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (NASDAQ: MBOT ), a medical device company specializing in [...]

CRISPR Therapeutics Presents Positive Data on Allogeneic CRISPR-based CAR-T Cell Therapies at AACR 2018

16/04/2018 - 22:01

-Off-the-shelf CAR-T candidates against BCMA and CD70 address both hematologic malignancies and solid tumors - -New data demonstrate high editing rates, consistent expression, selective and potent cell killing- ZUG, [...]